Cimaterol
- Level
- Commodity
- Parent
- 51391700
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51391710This classification denotes a beta-adrenergic agonist with the molecular formula C12H17N3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier ZPY8VRF0GB, chemically known as benzonitrile, 2-amino-5-(1-hydroxy-2-((1-methylethyl)amino)ethyl)-, (+-)- but generally known as cimaterol, which bears US NIH Compound Identifier 2755. European Medicines Agency schedules Cimaterol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06276MIG. The term CIMATEROL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 40, No. 6, 1986, List 26). CIMATEROL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule cimaterol under HS 29269095 and SITC 51484. As of Q4 2014, CIMATEROL remains the US FDA Preferred Term for this commodity. Cimaterol bears US NLM identifiers UMLS ID C0055730 and NCI Concept Code C76017. SMILES: CC(C)NCC(C1=CC(=C(C=C1)N)C#N)O.
Same parent
Under 51391700 · 48Activities that produce or sell this
KBLI · 8Inherited from family 51390000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.